Table 4.
Phase outcome | n | % of responses | % of respondentsa |
---|---|---|---|
Pre-surgical (n = 71) | |||
Patient-reported Health-related quality of life | 41 | 24.0 | 57.7 |
Patient-reported upper quadrant function | 58 | 33.9 | 81.7* |
Patient-reported fatigue | 12 | 7.0 | 16.9 |
Mobility and balance | 15 | 8.8 | 21.1 |
Upper extremity activity and motor control | 45 | 26.3 | 63.4 |
Post-surgical (n = 70) | |||
Patient-reported Health-related quality of life | 41 | 22.9 | 58.6 |
Patient-reported upper quadrant function | 58 | 32.4 | 82.9* |
Patient-reported fatigue | 22 | 12.3 | 31.4 |
Mobility and balance | 8 | 4.5 | 11.4 |
Upper extremity activity and motor control | 50 | 27.9 | 71.4* |
Subclinical/Surveillance (n = 71) | |||
Patient-reported Health-related quality of life | 45 | 26.8 | 63.4 |
Patient-reported upper quadrant function | 60 | 35.7 | 84.5* |
Patient-reported fatigue | 13 | 7.7 | 18.3 |
Mobility and balance | 7 | 4.2 | 9.9 |
Upper extremity activity and motor control | 43 | 25.6 | 60.6 |
Acute (n = 71) | |||
Patient-reported Health-related quality of life | 44 | 24.0 | 62.0 |
Patient-reported upper quadrant function | 64 | 35.0 | 90.1* |
Patient-reported fatigue | 16 | 8.7 | 22.5 |
Mobility and balance | 11 | 6.0 | 15.5 |
Upper extremity activity and motor control | 48 | 26.2 | 67.6 |
Chronic (n = 70) | |||
Patient-reported Health-related quality of life | 57 | 30.0 | 81.4* |
Patient-reported upper quadrant function | 61 | 32.1 | 87.1* |
Patient-reported fatigue | 15 | 7.9 | 21.4 |
Mobility and balance | 12 | 6.3 | 17.1 |
Upper extremity activity and motor control | 45 | 23.7 | 64.3 |
BCRL-Breast cancer-related lymphedema, ICF-International classification of functioning, Disability and Health
aMultiple responses for “select all”–the percent of respondents that chose each outcome measure as a highly recommended OM for the respective phase
*Met the minimum consensus threshold of 70%